利用TA克隆的方法简便构建入门克隆

Gateway技术是一种通用型克隆方法,其基于λ噬菌体位点特异性重组,将目的DNA快速克隆到各种与Gateway技术兼容的目的载体上,不需要进行酶切和连接反应。但存在获得入门克隆过程中相关反应酶制剂价格昂贵,且药品订购时间较长等问题。通过对入门载体pDONR207的改造,使之产生3’端具有单个T 末端的线性化的入门载体,采用TA克隆的方法替代BP反应,从而简便、经济和快速地获得入门克隆。利用改造后的Gateway技术构建拟南芥SOS2基因的原核表达载体和真核表达载体,通过原核表达和原生质体瞬时表达证明通过此方法构建的表达载体在原核细胞和真核细胞中都得到了很好的表达。     

含有Rubisco小亚基启动子和转运肽序列的通路克隆入门载体的构建和应用

Gateway(通路克隆)技术是最近开发出来的一种分子克隆技术,其特点是操作简单、省时高效,已经成功应用于很多基因表达载体的构建.然而,现有的通路克隆植物表达载体不包含任何将表达蛋白定位到叶绿体中的序列.将通路克隆入门质粒载体pENTR-2B的XmnⅠ位点改造成HindⅢ位点,产生入门载体pENTR*-2B,然后将番茄1,5二磷酸核酮糖羧化酶(Rubisco)小亚基3C的启动子(PrbcS)及其转运肽序列(*T)和绿色荧光蛋白(GFP)报告基因亚克隆到pENTR*-2B中,构建通路克隆入门载体pENTR*-PrbcS-*T-GFP.实验结果证实,用pENTR*-PrbcS-*T-GFP和通路克隆的植物表达载体进行LR反应,构建GFP的光诱导型植物表达载体,可以成功地将表达的GFP定位到转基因植物的叶绿体中.利用β-葡糖苷酸酶(GUS)报告基因替代该入门载体中的GFP基因做试验也得到相似的结果.这说明用目的基因替换该入门载体中的GFP可以构建目的基因的入门载体,然后用通路克隆技术可以快速构建其光诱导型植物表达载体,将表达的目的蛋白定位到转基因植物或组织细胞的叶绿体中.     

用于通路(Gateway)克隆技术的植物表达载体研究进展

通路(Gateway)克隆技术是根据λ噬菌体基因组和大肠杆菌基因组之间的位点专一性重组分子机制开发的一套分子克隆新技术.利用该技术LR反应构建目的基因的表达载体时不需要经过酶切和连接等繁琐而又费时的过程,因此,可以节省很多时间.为了扩大Gateway技术在植物基因工程领域的应用,最近有很多研究机构和研究小组开发了能用于组成型或诱导型表达目的基因、基因沉默、启动子分析、蛋白质亚细胞定位、蛋白质/蛋白质相互作用、多个DNA片段的模块化组装和DNA组片段功能验证等研究用的植物表达载体.该文对这些技术的研究进展进行了综述.     

转录因子DREB1A基因的克隆与Gateway克隆技术构建植物表达载体

目的:研究转录因子DREB1A在植物抗渗透胁迫反应中的作用,并探讨利用Gateway克隆技术构建植物表达载体的方法。方法:根据GenBank中登录的DREB1A基因的全长mRNA序列设计引物,克隆了拟南芥的转录因子DREBIA基因。根据Gateway克隆技术的要求,设计含有attB接头的引物,利用高保真的PlatinumpfxDNA聚合酶,通过PCR方法在克隆基因的两端加上B序列。通过BP反应将包含有attB接头的PCR产物克隆到含有attP的donor载体上以产生Entry克隆,通过LR反应将已经重组入Entry载体的DREB1A基因再克隆到pH2GW7双元载体。结果:对重组载体pH2GW7-DREB1A的鉴定结果表明成功构建了DREB1A基因的植物表达载体。结论:利用Gateway克隆技术构建植物表达载体简便易行,该结果为遗传转化研究奠定了基础。     

通路克隆入门载体pEN-L4~*-PrbcS-~*T-gfp-L3~*的构建及其应用

为了利用通路克隆(Gateway)技术构建一个含有两个目的基因表达盒的植物表达载体,并把目的基因编码的蛋白质定位到转基因植物的叶绿体中,通过定点突变技术,在含有attL4和attL3重组位点的Gateway入门载体pEN-L4-2-L3中产生HindⅢ和XhoⅠ的酶切位点,然后在这两个酶切位点之间插入一个含有1,5-二磷酸核酮糖羧化酶小亚基的光诱导型启动子(PrbcS)及其叶绿体基质定位序列(*T)和绿色荧光蛋白(GFP)报告基因(gfp)的DNA片段,获得pEN-L4*-PrbcS-*T-gfp-L3*入门载体.用该载体和另一个含有attL1和attL2重组位点的入门载体(pENTR*-PrbcS-*T-gus)与Gateway的目的载体pK7 m34GW2-8 m21GW3进行LR重组反应可以构建一个能串联gfp和gus两个报告基因表达盒的植物表达载体pKm-35S-PrbcS-*T-gfp-PROLD-PrbcS-*T-gus,所构建的植物表达载体转化烟草后,gfp和gus基因能插入到转基因烟草的基因组中并正常表达,所表达的GFP蛋白可正确定位到转基因植物的叶绿体中,而GUS蛋白也可以在叶片中表达.利用此表达载体通过一次转化事件不仅可以完成两个目的基因的转化操作,而且还可以利用叶绿体基质定位序列(*T)把PrbcS控制表达的目的蛋白直接定位到转基因植物的叶绿体中.因此pEN-L4*-PrbcS-*T-gfp-L3*入门载体的应用进一步扩大了Gateway技术及植物表达载体的应用范围,为叶绿体基因工程操作提供了一个更方便的技术平台.     

T载体介导的基于attL核心区LR反应的简化快速Gateway克隆系统

Gateway克隆技术已得到广泛的应用。该技术先通过BP反应将目标片段连到带有完整attL特异识别位点的入门载体,然后与终载体通过LR反应得到表达载体。Gateway克隆方法与传统的酶切连接方法相比有快速简单等优点。但是,BP和LR酶都非常昂贵。本研究首先对3个常用Gateway载体的atts特异位点序列比对发现,attL序列核心交换位点“core attL”的21~22 bp长的碱基是保守和必要的。由此,设计含有core-attL序列的引物,通过PCR克隆得到DNA片段并连入pMD18-T载体,然后进行LR反应,可成功得到目标表达载体,并在保守的位点上正确重组。本研究还对其中一个带有绿色荧光蛋白基因的表达载体转化至烟草,能够正常表达该蛋白质。结果表明,通过将含有attL核心位点基因片段连接到pMD18-T载体上,可以省略BP反应而将目标片段连接到终载体上,节约了反应时间和成本。     

以木糖异构酶基因xylA为选择标记的Gateway系统植物表达载体的构建

目的:构建以木糖异构酶基因xylA为筛选标记的无抗生素标记Gateway系统植物表达载体。方法:克隆大肠杆菌木糖异构酶基因xylA并用其替换植物表达载体pCAMBIA1301中的hpt基因,利用载体中的多克隆位点将Gateway Binary Vector(pH7WG2D)中酶切位点XbaⅠ和HindⅢ之间包括P35S、T35S、attR1、attR2和CmR-ccdB的片段重组入表达载体pCAMBIA1301中,构建表达载体pCAMBIA1301-xylA-GW,利用含有津田芜菁HY5基因片段的BP反应产物与载体进行LR反应,获得含有目的基因的植物表达载体pCAMBIA1301-xylA-HY5,并导入根癌农杆菌LBA4404中。结果:抗生素筛选及酶切和PCR鉴定表明成功构建了以xylA为筛选标记的无抗生素标记植物表达载体pCAMBIA1301-xylA-HY5。结论:利用木糖异构酶基因xylA结合Gateway克隆技术构建无抗生素标记植物表达载体,可简化、方便植物转基因表达载体构建。     

基于XcmⅠ酶切的高效TA克隆载体的构建

目的：制备基于XcmⅠ酶切的高效TA克隆载体,并检测其克隆PCR产物的效果。方法：设计一对互补配对的寡核苷酸,经过变性及退火后插入质粒pUC19的多克隆位点,从而在该多克隆位点中引入2个XcmⅠ酶切位点,用XcmⅠ酶切后即获得含有3’突出T碱基的T载体;为了提高该T载体的克隆效率,优化了2个XcmⅠ酶切位点之间的碱基数目,排除了载体自连产生白色克隆的可能性,使假阳性大大减少;此外,为了便于完全酶切与未完全酶切载体的分离,在2个XcmⅠ之间插入了一段无关DNA片段。结果：改进得到的T载体可以有效克隆PCR产物,其阳性克隆率可达95％。结论：构建了基于XcmⅠ酶切的TA克隆载体,经过改进的T载体具有很高的克隆效率。     

人PRKAG2全长基因的体外拼接及TA克隆载体的构建

目的:应用体外基因拼接及TA克隆技术构建含PRKAG2基因的载体.方法:通过商业途径购得PRKAG2基因的一个转录变体cDNA质粒(GenBank登记号BC 068598),其在N端缺失了44个氨基酸,根据已知的PRKAG2基因序列(GenBank登记号NM_016203),设计搭桥引物及序列扩增引物,通过PCR搭桥方法,合成完整全序列的PRKAG2基因,并将其克隆到TA载体,将得到的阳性克隆测序鉴定.结果:拼接出全长1759bp的PRKAG2基因,目的基因连接到载体后测序与设计的PRKAG2基因完全一致.结论:成功的构建了全长人PRKAG2基因的TA克隆,为进一步研究PRKAG2基因的功能提供了模板.     

基于XcmⅠ的T载体及其在合成生物学中的应用

为了节约成本和提高实验效率,以商用p MD18-T载体为基础,构建获得了p FL-XS-T载体,其具有符合Biobrick标准的串联XbaⅠ-XcmⅠ-XcmⅠ-SpeⅠ克隆序列,通过对XcmⅠ的酶切处理即可以通过TA克隆方便地克隆PCR片段。克隆验证实验结果表明,经XcmⅠ处理的该载体可以与PCR片段进行TA连接,连接效率及阳性率均可以满足实验室要求并且可以得到Biobrick标准质粒。此外,该载体不仅可以与其余Biobrick标准元件进行串联,还可以作为功能DNA元件的筛选载体。     

Using a modified TA cloning method to create entry clones

We describe a noncommercial alternative method to create entry clones compatible with all kinds of destination vectors based on an improved TA cloning approach. To generate Gateway T vectors, we first constructed gentamicin- and chloramphenicol-resistant entry vectors designated pGWG and pGWC, respectively. Each entry vector contains an AhdI cassette flanked by attL sites, with each AhdI cassette containing two AhdI restriction enzyme sites spaced by the ccdB killer gene, which is lethal to most Escherichia coli strains. Gateway T vectors can be prepared by simple digestion of these entry vectors with the AhdI enzyme or its isoschizomers. The use of the ccdB gene as a negative selection marker is an important improvement over conventional TA cloning in that it eliminates the necessity of blue/white color screening based on alpha-complementation. Another important improvement that we have implemented is to retail the T vectors using Taq polymerase and dTTP so as to improve the cloning efficiency. Together, these improvements allow TA cloning to realize its full potential. Using Gateway T vectors prepared by this improved method, entry clones for PCR products or restriction enzyme fragments can be created simply, efficiently, and inexpensively while at the same time introducing greater compatibility.     

High efficiency single step production of expression plasmids from cDNA clones using the Flexi Vector cloning system

The success of structural genomics and proteomics initiatives is dependent on the availability of target genes in vectors suitable for protein production. Here, we compare two high-throughput methods for producing expression vectors from plasmid-derived cDNA fragments. Expression vectors were constructed for compatibility with the Gateway recombination cloning system and the Flexi Vector restriction-based cloning system. Cloning protocols for each system were conducted in parallel for 96 different target genes from PCR through the production of sequence-verified expression clones. The short nucleotide sequences required to prepare the target open reading frames for Flexi Vector cloning allowed a single-step PCR protocol, resulting in fewer mutations relative to the Gateway protocol. Furthermore, through initial cloning of the target open reading frames directly into an expression vector, the Flexi Vector system gave time and cost savings compared to the protocol required for the Gateway system. Within the Flexi Vector system, genes were transferred between four different expression vectors. The efficiency of gene transfer between Flexi Vectors depended on including a region of sequence identity adjacent to one of the restriction sites. With the proper construction in the flanking sequence of the vector, gene transfer efficiencies of 95-98% were demonstrated.     

A Gateway MultiSite recombination cloning toolkit

The generation of DNA constructs is often a rate-limiting step in conducting biological experiments. Recombination cloning of single DNA fragments using the Gateway system provided an advance over traditional restriction enzyme cloning due to increases in efficiency and reliability. Here we introduce a series of entry clones and a destination vector for use in two, three, and four fragment Gateway MultiSite recombination cloning whose advantages include increased flexibility and versatility. In contrast to Gateway single-fragment cloning approaches where variations are typically incorporated into model system-specific destination vectors, our Gateway MultiSite cloning strategy incorporates variations in easily generated entry clones that are model system-independent. In particular, we present entry clones containing insertions of GAL4, QF, UAS, QUAS, eGFP, and mCherry, among others, and demonstrate their in vivo functionality in Drosophila by using them to generate expression clones including GAL4 and QF drivers for various trp ion channel family members, UAS and QUAS excitatory and inhibitory light-gated ion channels, and QUAS red and green fluorescent synaptic vesicle markers. We thus establish a starter toolkit of modular Gateway MultiSite entry clones potentially adaptable to any model system. An inventory of entry clones and destination vectors for Gateway MultiSite cloning has also been established (www.gatewaymultisite.org).     

A Versatile Zero Background T-Vector System for Gene Cloning and Functional Genomics

With the recent availability of complete genomic sequences of many organisms, high-throughput and cost-efficient systems for gene cloning and functional analysis are in great demand. Although site-specific recombination-based cloning systems, such as Gateway cloning technology, are extremely useful for efficient transfer of DNA fragments into multiple destination vectors, the two-step cloning process is time consuming and expensive. Here, we report a zero background TA cloning system that provides simple and high-efficiency direct cloning of PCR-amplified DNA fragments with almost no self-ligation. The improved T-vector system takes advantage of the restriction enzyme XcmI to generate a T-overhang after digestion and the negative selection marker gene ccdB to eliminate the self-ligation background after transformation. We demonstrate the feasibility and flexibility of the technology by developing a set of transient and stable transformation vectors for constitutive gene expression, gene silencing, protein tagging, protein subcellular localization detection, and promoter fragment activity analysis in plants. Because the system can be easily adapted for developing specialized expression vectors for other organisms, zero background TA provides a general, cost-efficient, and high-throughput platform that complements the Gateway cloning system for gene cloning and functional genomics.     

An Alternative Approach in Gateway® Cloning when the Bacterial Antibiotic Selection Cassettes of the Entry Clone and Destination Vector are the Same

The Gateway^® recombination technology has revolutionized the method of gene cloning for functional analyses and high-throughput ORFeome projects. In general, Gateway cloning is highly efficient because after LR recombination and bacterial transformation, only cells containing the recombinant destination clone are selected on an antibiotic selection plate. However, when the antibiotic resistance gene for bacterial selection is the same in the entry and destination vectors, the direct selection of recombinant destination clones on an antibiotic plate is difficult. Here, we demonstrate an efficient and comprehensive approach to obtain positive destination clones directly on an antibiotic selection plate in this situation. The strategy involves polymerase chain reaction (PCR)-mediated amplification of the entry clone using entry vector-specific primers that bind outside the attL sequences and the subsequent use of this purified PCR product for LR recombination with the destination vector. Our results suggest that cloning of linear DNA fragments into circular destination vectors through LR recombination is an efficient method for inserts up to 7 kb in size. Using this approach, the yield of colony PCR positive destination clones was 100 % for genes of various sizes tested in our experiments.     

From Gateway to MultiSite Gateway in one recombination event

Background  

Invitrogen Gateway technology exploits the integrase/att site-specific recombination system for directional cloning of PCR products and the subsequent subcloning into destination vectors. One or three DNA segments can be cloned using Gateway or MultiSite Gateway respectively. A vast number of single-site Gateway destination vectors have been created while MultiSite Gateway is limited to few destination vectors and therefore to few applications. The aim of this work was to make the MultiSite Gateway technology available for multiple biological purposes.     

A universal cloning vector using vaccinia topoisomerase I

Vaccinia DNA topoisomerase I (TOPO) charged vectors with a sticky T are routinely used to clone polymerase chain reaction (PCR) products with an extra A at their 3′ end (TOPO TA Cloning from Invitrogen). TOPO charged blunt vectors are used to clone blunt end PCR products (TOPO Blunt Cloning). Here, we demonstrate that both TOPO TA vectors and TOPO Blunt vectors can be used to clone PCR products with either a blunt end or an extra A at the 3′ end. We further demonstrate that these vectors can be used to clone sticky end DNA generated with restriction enzymes. In summary, these TOPO vectors can be used as universal cloning vectors.     

Rapid isolation of terminal sequences from cloned plant DNA fragments

The isolation of DNA clone termini is an important step in the development of DNA contigs utilized for a range of applications, including physical mapping, genetic map-based cloning, insertion mutagenesis cloning, and isolation of complete gene sequences. We describe a rapid PCR-based method for the isolation of vector-insert junctions, or insert terminal sequences, of cloned plant DNA fragments. PCR amplification is performed using a vector-specific primer and a nonspecific primer, originally designed for use in animal systems, containing degenerative bases that we have shown can also anneal to plant insert DNA. Using this method we have successfully isolated end-terminal sequences from plant genomic clones harbored in YAC, BAC, and bacteriophage λ vectors. Termini of genomic clones from both tomato andArabidopsis were isolated demonstrating the utility of this technique among a range of plant species.